328 related articles for article (PubMed ID: 16859699)
1. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
3. Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice.
de Brouwer KF; Degens H; Aartsen WM; Lindhout M; Bitsch NJ; Gilde AJ; Willemsen PH; Janssen BJ; van der Vusse GJ; van Bilsen M
J Mol Cell Cardiol; 2006 Jun; 40(6):838-45. PubMed ID: 16697005
[TBL] [Abstract][Full Text] [Related]
4. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
Huggins CE; Domenighetti AA; Pedrazzini T; Pepe S; Delbridge LM
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):186-90. PubMed ID: 14608525
[TBL] [Abstract][Full Text] [Related]
5. Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-alpha signaling pathway.
Meng RS; Pei ZH; Yin R; Zhang CX; Chen BL; Zhang Y; Liu D; Xu AL; Dong YG
Eur J Pharmacol; 2009 Oct; 620(1-3):63-70. PubMed ID: 19699196
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of high-fat diet on myocardial lipid metabolism in failing and nonfailing hearts with angiotensin II-mediated cardiac remodeling in mice.
Pellieux C; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
Am J Physiol Heart Circ Physiol; 2012 May; 302(9):H1795-805. PubMed ID: 22408021
[TBL] [Abstract][Full Text] [Related]
7. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
[TBL] [Abstract][Full Text] [Related]
8. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
Akki A; Seymour AM
Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
[TBL] [Abstract][Full Text] [Related]
9. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
Aasum E; Cooper M; Severson DL; Larsen TS
Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid metabolism assessed by 125I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts.
Miyamoto T; Takeishi Y; Tazawa S; Inoue M; Aoyama T; Takahashi H; Arimoto T; Shishido T; Tomoike H; Kubota I
Eur J Clin Invest; 2004 Mar; 34(3):176-81. PubMed ID: 15025675
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure.
Lei B; Lionetti V; Young ME; Chandler MP; d'Agostino C; Kang E; Altarejos M; Matsuo K; Hintze TH; Stanley WC; Recchia FA
J Mol Cell Cardiol; 2004 Apr; 36(4):567-76. PubMed ID: 15081316
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity.
Dewald O; Sharma S; Adrogue J; Salazar R; Duerr GD; Crapo JD; Entman ML; Taegtmeyer H
Circulation; 2005 Jul; 112(3):407-15. PubMed ID: 16009788
[TBL] [Abstract][Full Text] [Related]
14. Control of mitochondrial gene expression in the aging rat myocardium.
LeMoine CM; McClelland GB; Lyons CN; Mathieu-Costello O; Moyes CD
Biochem Cell Biol; 2006 Apr; 84(2):191-8. PubMed ID: 16609700
[TBL] [Abstract][Full Text] [Related]
15. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
Brigadeau F; Gelé P; Wibaux M; Marquié C; Martin-Nizard F; Torpier G; Fruchart JC; Staels B; Duriez P; Lacroix D
J Cardiovasc Pharmacol; 2007 Jun; 49(6):408-15. PubMed ID: 17577106
[TBL] [Abstract][Full Text] [Related]
16. Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.
Lionetti V; Linke A; Chandler MP; Young ME; Penn MS; Gupte S; d'Agostino C; Hintze TH; Stanley WC; Recchia FA
Cardiovasc Res; 2005 Jun; 66(3):454-61. PubMed ID: 15914110
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response.
Feingold K; Kim MS; Shigenaga J; Moser A; Grunfeld C
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E201-7. PubMed ID: 14701665
[TBL] [Abstract][Full Text] [Related]
18. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
Domenighetti AA; Boixel C; Cefai D; Abriel H; Pedrazzini T
J Mol Cell Cardiol; 2007 Jan; 42(1):63-70. PubMed ID: 17070838
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.
Crabb DW; Galli A; Fischer M; You M
Alcohol; 2004 Aug; 34(1):35-8. PubMed ID: 15670663
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy.
Higuchi Y; McTiernan CF; Frye CB; McGowan BS; Chan TO; Feldman AM
Circulation; 2004 Apr; 109(15):1892-7. PubMed ID: 15051641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
